Responses
Regular and young investigator award abstracts
Clinical trials in progress
330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
